litlas
ログインアカウント作成

Kosh Agarwal

2000–2025 年に発表

92
論文数
19,046
被引用数
52
h 指数
85
i10 指数

被引用数

Kosh Agarwal の年別被引用数1996 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 1 件2001 年: 被引用 8 件2002 年: 被引用 14 件2003 年: 被引用 7 件2004 年: 被引用 6 件2005 年: 被引用 7 件2006 年: 被引用 3 件2007 年: 被引用 16 件2008 年: 被引用 8 件2009 年: 被引用 4 件2010 年: 被引用 10 件2011 年: 被引用 12 件2012 年: 被引用 23 件2013 年: 被引用 25 件2014 年: 被引用 54 件2015 年: 被引用 137 件2016 年: 被引用 173 件2017 年: 被引用 191 件2018 年: 被引用 250 件2019 年: 被引用 806 件2020 年: 被引用 809 件2021 年: 被引用 726 件2022 年: 被引用 495 件2023 年: 被引用 410 件2024 年: 被引用 702 件2025 年: 被引用 305 件2026 年: 被引用 4 件1997〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,318 件、この内訳の 18.4%中国: 引用元論文 753 件、この内訳の 10.5%イギリス: 引用元論文 496 件、この内訳の 6.9%イタリア: 引用元論文 407 件、この内訳の 5.7%ドイツ: 引用元論文 367 件、この内訳の 5.1%フランス: 引用元論文 315 件、この内訳の 4.4%カナダ: 引用元論文 287 件、この内訳の 4%スペイン: 引用元論文 240 件、この内訳の 3.4%日本: 引用元論文 236 件、この内訳の 3.3%台湾: 引用元論文 226 件、この内訳の 3.2%韓国: 引用元論文 209 件、この内訳の 2.9%オーストラリア: 引用元論文 186 件、この内訳の 2.6%
0%18.4%その他 29.6%

機関

分野

  • Medicine90.4%
  • Biochemistry, Genetics and Molecular Biology4.5%
  • Immunology and Microbiology1.8%
  • Neuroscience1%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Computer Science0.3%
  • その他1.2%

トピック

  • Hepatitis C virus research20.5%
  • Hepatitis B Virus Studies18%
  • Liver Disease Diagnosis and Treatment12.1%
  • Hepatitis Viruses Studies and Epidemiology4.8%
  • HIV/AIDS drug development and treatment3.6%
  • Liver Disease and Transplantation2.9%
  • その他38.1%

共著者

全論文

検索で開く
  1. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

    著者: Pietro Lampertico, Kosh Agarwal, Thomas Berg, Marı́a Buti, Harry L.A. Janssen, George Papatheodoridis, Fabien Zoulim, Frank Tacke - Journal of Hepatology 2017 被引用: 5,440

  2. EASL Clinical Practice Guidelines on hepatitis delta virus

    著者: Maurizia Rossana Brunetto, G. Ricco, Francesco Negro, Heiner Wedemeyer, Cihan Yurdaydın, Tarik Asselah, George Papatheodoridis, Liana Gheorghe, Kosh Agarwal, Patrizia Farci, Marı́a Buti - Journal of Hepatology 2023 被引用: 252

  3. The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

    著者: Michael Trauner, Aliya Gulamhusein, Bilal Hameed, Stephen H. Caldwell, Mitchell L. Shiffman, Charles Landis, Bertus Eksteen, Kosh Agarwal, Andrew J. Muir, Simon Rushbrook, Xiaomin Lu, Jun Xu, Jen‐Chieh Chuang, Andrew N. Billin, Georgia Li, Chuhan Chung, G. Mani Subramanian, Robert P. Myers, Christopher L. Bowlus, Kris V. Kowdley - Hepatology 2019 被引用: 259

  4. New Approaches to Chronic Hepatitis B

    著者: Geoffrey Dusheiko, Kosh Agarwal, Mala K. Maini - New England Journal of Medicine 2023 被引用: 168

  5. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

    著者: Henry Lik‐Yuen Chan, Scott Fung, Wai Kay Seto, Wan‐Long Chuang, Chi-Yi Chen, Hyung Joon Kim, Aric J. Hui, Harry L.A. Janssen, Abhijit Chowdhury, Tak Yin Owen Tsang, Rajiv Mehta, Edward Gane, John F. Flaherty, Benedetta Massetto, Anuj Gaggar, Kathryn M. Kitrinos, Lanjia Lin, G. Mani Subramanian, John G. McHutchison, Young‐Suk Lim, Subrat Kumar Acharya, Kosh Agarwal - ˜The œLancet. Gastroenterology & hepatology 2016 被引用: 458

  6. 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

    著者: Kosh Agarwal, Maurizia Rossana Brunetto, Wai Kay Seto, Young‐Suk Lim, Scott Fung, Patrick Marcellin, Sang Hoon Ahn, Namiki Izumi, Wan‐Long Chuang, Ho Bae, Manoj Sharma, Harry L.A. Janssen, Calvin Q. Pan, Mustafa Kemal Çelen, Norihiro Furusyo, S. Shalimar, Ki Tae Yoon, Huy N. Trinh, John F. Flaherty, Anuj Gaggar, Audrey Lau, Andrea L. Cathcart, Lanjia Lin, Neeru Bhardwaj, Vithika Suri, G. Mani Subramanian, Edward Gane, Marı́a Buti, Henry Lik‐Yuen Chan - Journal of Hepatology 2018 被引用: 423

  7. Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

    著者: Jordan J. Feld, Ira M. Jacobson, Christophe Hézode, Tarik Asselah, Peter Ruane, Norbert H. Gruener, Armand Abergel, Alessandra Mangia, Ching‐Lung Lai, Henry Lik‐Yuen Chan, Francesco Mazzotta, Christophe Moreno, Eric M. Yoshida, Stephen D. Shafran, William Towner, Tram T. Tran, John McNally, Anu Osinusi, Evguenia S. Svarovskaia, Yanni Zhu, Diana M. Brainard, John G. McHutchison, Kosh Agarwal, Stefan Zeuzem - New England Journal of Medicine 2015 被引用: 1,116

  8. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19

    著者: Saima Ajaz, Mark McPhail, Keshav K. Singh, Salma Mujib, Francesca M. Trovato, Salvatore Napoli, Kosh Agarwal - American Journal of Physiology-Cell Physiology 2020 被引用: 227

  9. Pregenomic HBV RNA and Hepatitis B Core‐Related Antigen Predict Outcomes in Hepatitis B e Antigen–Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy

    著者: Ivana Carey, Jeffrey Gersch, Bo Wang, Christiana Moigboi, Mary C. Kuhns, Gavin Cloherty, Geoffrey Dusheiko, Kosh Agarwal - Hepatology 2019 被引用: 171

  10. Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD)

    著者: Saima Ajaz, Mark McPhail, Luigi Gnudi, Francesca M. Trovato, Salma Mujib, Salvatore Napoli, Ivana Carey, Kosh Agarwal - Mitochondrion 2020 被引用: 88

  11. Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)

    著者: Milan J. Sonneveld, Jun Yong Park, Apichat Kaewdech, Wai‐Kay Seto, Yasuhito Tanaka, Ivana Carey, Μargarita Papatheodoridi, Florian van Bömmel, Thomas Berg, Fabien Zoulim, Sang Hoon Ahn, George Ν. Dalekos, Nicole S. Erler, Christoph Höner zu Siederdissen, Heiner Wedemeyer, Markus Cornberg, Man‐Fung Yuen, Kosh Agarwal, André Boonstra, Marı́a Buti, Teerha Piratvisuth, George Papatheodoridis, Benjamin Maasoumy - Clinical Gastroenterology and Hepatology 2020 被引用: 103

  12. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study

    著者: Pietro Lampertico, Marı́a Buti, Scott Fung, Sang Hoon Ahn, Wan‐Long Chuang, Won Young Tak, Alnoor Ramji, Chi-Yi Chen, Edward Tam, Ho Bae, Xiaoli Ma, John F. Flaherty, Anuj Gaggar, Audrey Lau, Yang Liu, George Y. Wu, Vithika Suri, Susanna K. Tan, G. Mani Subramanian, Huy N. Trinh, Seung Kew Yoon, Kosh Agarwal, Young‐Suk Lim, Henry Lik‐Yuen Chan - ˜The œLancet. Gastroenterology & hepatology 2020 被引用: 139

  13. A case of HBV-induced liver failure in the REEF-2 phase II trial: Implications for finite treatment strategies in HBV ‘cure’

    著者: Kosh Agarwal, James Lok, Ivana Carey, Yatin Shivkar, Michael Biermer, Thomas Berg, Isabelle Lonjon‐Domanec - Journal of Hepatology 2022 被引用: 67

  14. Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

    著者: Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts, Norbert Bräu, Edward Gane, Stephen Pianko, Eric Lawitz, Alexander Thompson, Mitchell L. Shiffman, Curtis Cooper, William Towner, Brian Conway, Peter Ruane, Marc Bourlière, Tarik Asselah, Thomas Berg, Stefan Zeuzem, William Rosenberg, Kosh Agarwal, Catherine Stedman, Hongmei Mo, Hadas Dvory‐Sobol, Lingling Han, Jing Wang, John McNally, Anu Osinusi, Diana M. Brainard, John G. McHutchison, Francesco Mazzotta, Tram T. Tran, Stuart C. Gordon, Keyur Patel, Nancy Reau, Alessandra Mangia, Mark Sulkowski - New England Journal of Medicine 2015 被引用: 850

  15. Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels

    著者: Milan J. Sonneveld, Shao‐Ming Chiu, Jun Yong Park, Sylvia M. Brakenhoff, Apichat Kaewdech, Wai‐Kay Seto, Yasuhito Tanaka, Ivana Carey, Μargarita Papatheodoridi, Florian van Bömmel, Thomas Berg, Fabien Zoulim, Sang Hoon Ahn, George Ν. Dalekos, Nicole S. Erler, Christoph Höner zu Siederdissen, Heiner Wedemeyer, Markus Cornberg, Man‐Fung Yuen, Kosh Agarwal, André Boonstra, Marı́a Buti, Teerha Piratvisuth, George Papatheodoridis, Chien‐Hung Chen, Benjamin Maasoumy - Journal of Hepatology 2022 被引用: 122

  16. Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety

    著者: Henry Lik‐Yuen Chan, Marı́a Buti, Young‐Suk Lim, Kosh Agarwal, Patrick Marcellin, Maurizia Rossana Brunetto, Wan‐Long Chuang, Harry L.A. Janssen, Scott Fung, Namiki Izumi, Dzhamal Abdurakhmanov, Maciej Jabłkowski, Mustafa Kemal Çelen, Xiaoli Ma, Florin Alexandru Căruntu, John F. Flaherty, Frida Abramov, Hongyuan Wang, Grégory Camus, Anu Osinusi, Calvin Q. Pan, S. Shalimar, Wai‐Kay Seto, Edward Gane, on behalf of the GS-US-320-0110 and GS-US-320-0108 investigators - The American Journal of Gastroenterology 2023 被引用: 60

  17. JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2

    著者: Kosh Agarwal, Marı́a Buti, Florian van Bömmel, Pietro Lampertico, Ewa Janczewska, Marc Bourlière, Thomas Vanwolleghem, Oliver Lenz, Thierry Verbinnen, Thomas N. Kakuda, Cristiana Mayer, John Jezorwski, Daniel G. Muenz, Maria Beumont, Ronald Kalmeijer, Michael Biermer, Isabelle Lonjon‐Domanec - Journal of Hepatology 2024 被引用: 47

  18. Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

    著者: Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo, Mario Chojkier, Norman Gitlin, Massimo Puoti, Manuel Romero‐Gómez, Jean-Pierre Zarski, Kosh Agarwal, Peter Buggisch, Graham R. Foster, Norbert Bräu, Marı́a Buti, Ira M. Jacobson, G. Mani Subramanian, Xiao Ding, Hongmei Mo, Jenny C. Yang, Phillip S. Pang, William T. Symonds, John G. McHutchison, Andrew J. Muir, Alessandra Mangia, Patrick Marcellin - New England Journal of Medicine 2014 被引用: 1,708

  19. Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

    著者: Michelle Cheung, Alex J Walker, Ben Hudson, Suman Verma, John McLauchlan, David Mutimer, Ashley Brown, William Gelson, Douglas MacDonald, Kosh Agarwal, Graham R. Foster, William L. Irving - Journal of Hepatology 2016 被引用: 408

  20. Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome

    著者: Alice Russell, Nilay Hepgul, Naghmeh Nikkheslat, Alessandra Borsini, Zuzanna Zajkowska, Natalie Moll, Daniel Forton, Kosh Agarwal, Trudie Chalder, Valeria Mondelli, Matthew Hotopf, Anthony J. Cleare, Gabrielle Murphy, Graham R. Foster, Terry Wong, Gregor Schütze, Markus Schwarz, Neil A. Harrison, Patricia A. Zunszain, Carmine M. Pariante - Psychoneuroendocrinology 2018 被引用: 86

  21. Clinical phenotype of adult‐onset liver disease in patients with variants in ABCB4 , ABCB11 , and ATP8B1

    著者: Jeremy Nayagam, Pierre Foskett, Sandra Strautnieks, Kosh Agarwal, Rosa Miquel, Deepak Joshi, Richard J. Thompson - Hepatology Communications 2022 被引用: 52

  22. Safety and efficacy of vesatolimod (GS‐9620) in patients with chronic hepatitis B who are not currently on antiviral treatment

    著者: Kosh Agarwal, Sang Hoon Ahn, M Elkhashab, Audrey Lau, Anuj Gaggar, Anuradha Bulusu, Xiaolu Tian, Andrea L. Cathcart, J Woo, G. Mani Subramanian, Pietro Andreoné, H. J. Kim, Wan‐Long Chuang, Mindie H. Nguyen - Journal of Viral Hepatitis 2018 被引用: 93

  23. Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial

    著者: Man‐Fung Yuen, Kosh Agarwal, Edward Gane, Christian Schwabe, Sang Hoon Ahn, Dong Joon Kim, Young‐Suk Lim, Wendy Cheng, William Sievert, Kumar Visvanathan, Eric Ruby, Sandy Liaw, Ran Yan, Qi Huang, Richard J. Colonno, Uri Lopatin - ˜The œLancet. Gastroenterology & hepatology 2019 被引用: 107

  24. Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection

    著者: Man‐Fung Yuen, Kosh Agarwal, Xiaoli Ma, Tuan Nguyen, Eugene R. Schiff, Hie‐Won Hann, Douglas T. Dieterich, Ronald Nahass, James Park, Sing Chan, Steven‐Huy B. Han, Edward Gane, Michael Bennett, Katia Alves, Marc Evanchik, Ran Yan, Qi Huang, Uri Lopatin, Richard J. Colonno, Julie Ma, Steven Knox, Luisa M. Stamm, Maurizio Bonacini, Ira M. Jacobson, Walid S. Ayoub, Frank Weilert, Natarajan Ravendhran, Alnoor Ramji, Paul Y. Kwo, Magdy Elkhashab, Tarek Hassanein, Ho Bae, Jacob Lalezari, Scott Fung, Mark Sulkowski - Journal of Hepatology 2022 被引用: 35